Vonafexor accepted as the generic name for EYP001 by the WHO

Published on 19/11/2020

We are pleased to announce that the World Health Organization (WHO) has accepted the international non-proprietary name (INN, or generic name) vonafexor for our FXR agonist lead candidate previously referred to as EYP001.

Read next in 'Latest news'

• New publication : A new class of molecule targeting the NEET family of proteins
• New release of neXtProt with ENYO Pharma human interactome data
• ENYO Pharma selected in the FrenchTech 120
• Collaboration with the Swiss Institute of Bioinformatics
• New offices in Lyon